Oncotelic Therapeutics Inc (OTLC) stock news · P/E 0.1, rev $250.0K
Oncotelic Therapeutics Inc (OTLC) is a biotechnology company listed on OTCQB.
This OTLC news page leads with what Oncotelic Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for OTLC yet. We will not pad this page with generic market recap.
Latest reported OTLC revenue for 2026-06-30 was $250.0K. Net income was -$1.8M. OTLC currently screens at market cap $17.8M and trailing P/E 0.1.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the OTLC stock page; for the tape open the quote page.
Not investment advice.